Efficacy and Safety Study of BIBW 2992 to Treat Lung Cancer Patients (TIMELY)

This study is currently recruiting participants.
Verified April 2013 by University College, London
Sponsor:
Collaborator:
Boehringer Ingelheim
Information provided by (Responsible Party):
University College, London
ClinicalTrials.gov Identifier:
NCT01415011
First received: August 10, 2011
Last updated: April 3, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2015
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)